glp-1 contraindications Therapy Part 1: Setting Realistic Weight Loss Expectations – Sarah Hormachea glp 1 receptor agonists contraindications

Richter B, Bandeira-Echtler E, Bergerhoff K, Lerch C

The authors also note that while most meta-analyses show no increase in risk, a few report elevated thyroid cancer incidence, but these analyses exhibit methodological fragility

Obesity and pancreatitis

Transcellular passage is also minimal, as peptides exceed Lipinskis Rule of Five (Ro5) limits and carry many hydrogen-bond donors/acceptors, both of which further contribute to extremely low oral bioavailability

Rather than targeting GLP-1 receptors alone, it's a dual agonist activating both GLP-1 and GIP (glucose-dependent insulinotropic polypeptide) receptors simultaneously